Dr Ricardo Aaron Miranda, MD | |
12222 N Central Expy # 150, Dallas, TX 75243-3755 | |
(469) 298-1444 | |
(918) 403-6335 |
Full Name | Dr Ricardo Aaron Miranda |
---|---|
Gender | Male |
Speciality | Pain Management |
Experience | 15 Years |
Location | 12222 N Central Expy # 150, Dallas, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083929087 | NPI | - | NPPES |
200599300A | Medicaid | OK |
Facility Name | Location | Facility Type |
---|---|---|
Jps Health Network | Fort worth, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Acclaim Physician Group Inc | 4587963582 | 439 |
News Archive
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a compound in soybeans is effective in reducing the frequency and severity of hot flashes in menopausal women.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
The emergence of this variant highlighted the uneven pace of mutation and selection of variants. New bioinformatics tools are the need of the hour to clarify this and confirm a dynamic evolution by tracking the mutation rates of the spike protein. It generally takes 1 – 6 months for current variants causing COVID-19 case peaks and deaths to survive the pressure of selection.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide.
› Verified 4 days ago
Entity Name | Acclaim Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a compound in soybeans is effective in reducing the frequency and severity of hot flashes in menopausal women.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
The emergence of this variant highlighted the uneven pace of mutation and selection of variants. New bioinformatics tools are the need of the hour to clarify this and confirm a dynamic evolution by tracking the mutation rates of the spike protein. It generally takes 1 – 6 months for current variants causing COVID-19 case peaks and deaths to survive the pressure of selection.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ricardo Aaron Miranda, MD 504 N Reo St, Tampa, FL 33609-1013 Ph: (813) 549-2134 | Dr Ricardo Aaron Miranda, MD 12222 N Central Expy # 150, Dallas, TX 75243-3755 Ph: (469) 298-1444 |
News Archive
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a compound in soybeans is effective in reducing the frequency and severity of hot flashes in menopausal women.
Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.
The emergence of this variant highlighted the uneven pace of mutation and selection of variants. New bioinformatics tools are the need of the hour to clarify this and confirm a dynamic evolution by tracking the mutation rates of the spike protein. It generally takes 1 – 6 months for current variants causing COVID-19 case peaks and deaths to survive the pressure of selection.
St. Jude Children's Research Hospital scientists have discovered a mechanism by which intracellular pathogens can shut down one of the body's key chemical weapons against them: nitric oxide.
› Verified 4 days ago
Lisa-ann Wuermser, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8200 Walnut Hill Ln, Dallas, TX 75231 Phone: 763-520-0453 | |
Dr. Matt Y. Bayazitoglu, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 411 N Washington Ave, Suite 4000, Dallas, TX 75246 Phone: 214-820-8557 Fax: 214-480-8356 | |
Tracey Rae Adams, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2301 S Hampton Rd, Suite 800, Dallas, TX 75224 Phone: 214-534-8913 | |
Desi Elpidio Barroga, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7515 Greenville Ave Ste 700, Dallas, TX 75231 Phone: 214-369-7881 Fax: 214-369-7882 | |
Dr. Deno B Barroga, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 7515 Greenville Ave, Ste 700, Dallas, TX 75231 Phone: 214-369-7881 Fax: 214-369-7882 | |
Dr. Brandt Gros, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3500 Oak Lawn Ave Ste 670, Dallas, TX 75219 Phone: 214-528-3378 Fax: 214-528-3379 | |
Wendy E. Goodwin, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dept. Of Physical Medicine & Rehabilitation, Dallas, TX 75390 Phone: 214-648-2733 |